| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 99 | 2021 | 9445 | 2.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 60 | 2021 | 8432 | 1.490 |
Why?
|
| Neoplasms | 52 | 2024 | 21696 | 1.470 |
Why?
|
| Cell Line, Tumor | 81 | 2021 | 16690 | 1.240 |
Why?
|
| Genetic Heterogeneity | 7 | 2019 | 733 | 1.110 |
Why?
|
| Genome, Human | 21 | 2021 | 4420 | 1.050 |
Why?
|
| Small Molecule Libraries | 12 | 2020 | 720 | 1.000 |
Why?
|
| Mutation | 56 | 2024 | 29786 | 0.980 |
Why?
|
| Drug Screening Assays, Antitumor | 6 | 2019 | 730 | 0.930 |
Why?
|
| Genomics | 24 | 2022 | 5717 | 0.900 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 41 | 2022 | 3921 | 0.900 |
Why?
|
| Neoplasm Proteins | 18 | 2021 | 3707 | 0.890 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 | 2007 | 1520 | 0.870 |
Why?
|
| Drug Resistance, Neoplasm | 16 | 2023 | 5172 | 0.800 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 14 | 2018 | 1378 | 0.800 |
Why?
|
| DNA Copy Number Variations | 11 | 2022 | 1941 | 0.790 |
Why?
|
| Leukemia, Myeloid | 9 | 2015 | 707 | 0.780 |
Why?
|
| Transcription Factors | 39 | 2022 | 12207 | 0.780 |
Why?
|
| Genomic Instability | 5 | 2019 | 695 | 0.770 |
Why?
|
| Cell Survival | 19 | 2024 | 5882 | 0.760 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 232 | 0.760 |
Why?
|
| Transcription, Genetic | 23 | 2020 | 7721 | 0.730 |
Why?
|
| Oncogene Proteins, Fusion | 14 | 2009 | 1581 | 0.720 |
Why?
|
| Organ Specificity | 4 | 2020 | 2008 | 0.690 |
Why?
|
| Neoplasm Metastasis | 10 | 2020 | 4851 | 0.690 |
Why?
|
| Copper | 1 | 2022 | 366 | 0.690 |
Why?
|
| Chromosome Aberrations | 9 | 2018 | 1813 | 0.680 |
Why?
|
| Translocation, Genetic | 17 | 2015 | 1420 | 0.670 |
Why?
|
| Gene Expression | 20 | 2016 | 7798 | 0.670 |
Why?
|
| Drug Repositioning | 2 | 2020 | 230 | 0.660 |
Why?
|
| MicroRNAs | 20 | 2019 | 3751 | 0.650 |
Why?
|
| DNA-Binding Proteins | 32 | 2020 | 9647 | 0.640 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2023 | 3595 | 0.620 |
Why?
|
| Leukemia | 11 | 2013 | 1510 | 0.620 |
Why?
|
| Evolution, Molecular | 3 | 2019 | 1939 | 0.610 |
Why?
|
| Oncogenes | 12 | 2019 | 1265 | 0.610 |
Why?
|
| Chromosomes, Human, Pair 12 | 11 | 1997 | 462 | 0.600 |
Why?
|
| Antineoplastic Agents | 28 | 2020 | 13693 | 0.590 |
Why?
|
| Breast Neoplasms | 22 | 2023 | 20824 | 0.590 |
Why?
|
| Repressor Proteins | 15 | 2002 | 3024 | 0.580 |
Why?
|
| Cell Differentiation | 33 | 2019 | 11486 | 0.560 |
Why?
|
| Gene Dosage | 10 | 2017 | 1252 | 0.550 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 1707 | 0.540 |
Why?
|
| RNA Interference | 12 | 2023 | 2890 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2012 | 4554 | 0.530 |
Why?
|
| DNA, Neoplasm | 11 | 2019 | 1758 | 0.530 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2014 | 2214 | 0.520 |
Why?
|
| Gene Expression Regulation | 21 | 2018 | 12073 | 0.520 |
Why?
|
| Humans | 267 | 2024 | 744366 | 0.520 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 137 | 0.510 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2016 | 136 | 0.500 |
Why?
|
| Cell Transformation, Neoplastic | 20 | 2016 | 2943 | 0.500 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2006 | 434 | 0.500 |
Why?
|
| Neoplastic Stem Cells | 7 | 2022 | 1376 | 0.500 |
Why?
|
| High-Throughput Screening Assays | 6 | 2017 | 944 | 0.480 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2019 | 5534 | 0.470 |
Why?
|
| Genes, Neoplasm | 6 | 2018 | 376 | 0.440 |
Why?
|
| Mice | 78 | 2024 | 81201 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2008 | 403 | 0.430 |
Why?
|
| Hepatitis C, Chronic | 2 | 2013 | 1031 | 0.430 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2016 | 934 | 0.420 |
Why?
|
| Lipoylation | 2 | 2023 | 72 | 0.420 |
Why?
|
| Liver Neoplasms | 6 | 2014 | 4253 | 0.410 |
Why?
|
| Proto-Oncogene Proteins B-raf | 6 | 2019 | 2043 | 0.410 |
Why?
|
| Multiple Myeloma | 3 | 2016 | 5181 | 0.410 |
Why?
|
| bcl-X Protein | 3 | 2012 | 411 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2016 | 1375 | 0.400 |
Why?
|
| Mitochondria | 4 | 2022 | 3514 | 0.400 |
Why?
|
| Receptors, Androgen | 4 | 2006 | 1058 | 0.400 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 4 | 2018 | 378 | 0.400 |
Why?
|
| Isoquinolines | 2 | 2016 | 366 | 0.390 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 3590 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2016 | 3390 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 7 | 2014 | 2455 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 21 | 6 | 2006 | 230 | 0.380 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.380 |
Why?
|
| Ecosystem | 1 | 2015 | 474 | 0.380 |
Why?
|
| DNA Mutational Analysis | 15 | 2021 | 4185 | 0.380 |
Why?
|
| Aneuploidy | 3 | 2021 | 530 | 0.380 |
Why?
|
| Animals | 89 | 2024 | 168768 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 6 | 2018 | 2012 | 0.370 |
Why?
|
| Drug Discovery | 4 | 2018 | 1058 | 0.370 |
Why?
|
| Quinazolines | 7 | 2014 | 1356 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2012 | 1434 | 0.360 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 293 | 0.360 |
Why?
|
| Erythroid Cells | 2 | 2008 | 239 | 0.350 |
Why?
|
| Cell Proliferation | 28 | 2023 | 10483 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 4463 | 0.350 |
Why?
|
| Cell Movement | 2 | 2020 | 5218 | 0.350 |
Why?
|
| Gene Amplification | 10 | 2018 | 1063 | 0.350 |
Why?
|
| Medulloblastoma | 4 | 2024 | 683 | 0.340 |
Why?
|
| Cerebellar Neoplasms | 3 | 2024 | 587 | 0.340 |
Why?
|
| Sequence Analysis, DNA | 11 | 2023 | 4805 | 0.340 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2017 | 640 | 0.340 |
Why?
|
| Glioma | 7 | 2022 | 3401 | 0.340 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 3 | 2008 | 187 | 0.330 |
Why?
|
| ras Proteins | 3 | 2012 | 1060 | 0.330 |
Why?
|
| Computational Biology | 9 | 2018 | 3519 | 0.330 |
Why?
|
| Aurintricarboxylic Acid | 1 | 2008 | 11 | 0.320 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 258 | 0.320 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7882 | 0.320 |
Why?
|
| Ribosomal Proteins | 2 | 2008 | 360 | 0.320 |
Why?
|
| Signal Transduction | 32 | 2018 | 23404 | 0.320 |
Why?
|
| Bone Marrow | 4 | 2016 | 2948 | 0.310 |
Why?
|
| Liver Cirrhosis | 3 | 2014 | 1862 | 0.310 |
Why?
|
| Prostatic Neoplasms | 17 | 2017 | 11126 | 0.310 |
Why?
|
| Melanoma | 11 | 2013 | 5511 | 0.310 |
Why?
|
| Cell Lineage | 13 | 2017 | 2504 | 0.310 |
Why?
|
| Early Diagnosis | 1 | 2013 | 1184 | 0.310 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 4 | 1997 | 97 | 0.300 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2020 | 2949 | 0.300 |
Why?
|
| Histone Deacetylase Inhibitors | 5 | 2019 | 789 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-ets | 16 | 2002 | 318 | 0.300 |
Why?
|
| Interferon-alpha | 2 | 2009 | 895 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 9 | 2016 | 3524 | 0.300 |
Why?
|
| Tumor Cells, Cultured | 20 | 2017 | 6313 | 0.300 |
Why?
|
| Brain Neoplasms | 9 | 2022 | 8861 | 0.300 |
Why?
|
| Glioblastoma | 5 | 2018 | 3481 | 0.290 |
Why?
|
| Open Reading Frames | 4 | 2024 | 811 | 0.290 |
Why?
|
| Biotechnology | 1 | 2008 | 281 | 0.280 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 3799 | 0.280 |
Why?
|
| Proteomics | 6 | 2018 | 3638 | 0.280 |
Why?
|
| Models, Genetic | 9 | 2019 | 3493 | 0.280 |
Why?
|
| DNA | 5 | 2023 | 7294 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2018 | 6542 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 5 | 2017 | 1070 | 0.270 |
Why?
|
| Single-Cell Analysis | 5 | 2020 | 2182 | 0.260 |
Why?
|
| Protein Biosynthesis | 5 | 2024 | 2126 | 0.260 |
Why?
|
| Cell Line | 20 | 2023 | 16000 | 0.260 |
Why?
|
| Neoplasm Transplantation | 6 | 2020 | 2086 | 0.260 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 1525 | 0.260 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4839 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 6 | 2021 | 2725 | 0.250 |
Why?
|
| Cytarabine | 1 | 2007 | 692 | 0.250 |
Why?
|
| Cell Respiration | 2 | 2023 | 201 | 0.250 |
Why?
|
| Megakaryocytes | 2 | 2008 | 545 | 0.250 |
Why?
|
| Bone Neoplasms | 4 | 2014 | 2530 | 0.250 |
Why?
|
| Proto-Oncogenes | 5 | 2005 | 321 | 0.250 |
Why?
|
| RNA, Neoplasm | 6 | 2011 | 769 | 0.240 |
Why?
|
| Clone Cells | 2 | 2018 | 1692 | 0.240 |
Why?
|
| Rhabdoid Tumor | 2 | 2019 | 212 | 0.240 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2016 | 179 | 0.240 |
Why?
|
| Mass Spectrometry | 3 | 2018 | 2204 | 0.240 |
Why?
|
| Species Specificity | 4 | 2017 | 2478 | 0.240 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 195 | 0.240 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 8 | 2012 | 345 | 0.240 |
Why?
|
| Sulfurtransferases | 1 | 2023 | 17 | 0.230 |
Why?
|
| Ferredoxins | 1 | 2023 | 10 | 0.230 |
Why?
|
| Down-Regulation | 12 | 2018 | 3001 | 0.230 |
Why?
|
| Benzamides | 6 | 2019 | 1379 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 91 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2021 | 17446 | 0.230 |
Why?
|
| Gene Rearrangement | 9 | 2018 | 1179 | 0.230 |
Why?
|
| Lymphoma, B-Cell | 6 | 2005 | 931 | 0.230 |
Why?
|
| Hematopoiesis | 7 | 2011 | 2073 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 51 | 0.230 |
Why?
|
| Apoptosis | 20 | 2019 | 9724 | 0.230 |
Why?
|
| Neuroblastoma | 3 | 2018 | 1226 | 0.230 |
Why?
|
| Nucleic Acid Probes | 1 | 2002 | 9 | 0.230 |
Why?
|
| Adenocarcinoma | 10 | 2016 | 6364 | 0.230 |
Why?
|
| Radiation Tolerance | 2 | 2016 | 486 | 0.220 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 4 | 1997 | 180 | 0.220 |
Why?
|
| Liver | 6 | 2013 | 7475 | 0.220 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2011 | 1097 | 0.220 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2022 | 11 | 0.210 |
Why?
|
| Cyclins | 2 | 2020 | 603 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2010 | 1790 | 0.210 |
Why?
|
| RNA, Messenger | 24 | 2013 | 13035 | 0.210 |
Why?
|
| Cells, Cultured | 14 | 2019 | 19233 | 0.210 |
Why?
|
| Ionophores | 1 | 2022 | 108 | 0.210 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2421 | 0.210 |
Why?
|
| Cluster Analysis | 9 | 2015 | 2715 | 0.210 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2022 | 69 | 0.210 |
Why?
|
| Prognosis | 18 | 2020 | 29060 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4479 | 0.200 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2022 | 82 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 12 | 2012 | 6171 | 0.200 |
Why?
|
| Immunologic Memory | 1 | 2008 | 1348 | 0.200 |
Why?
|
| Hematologic Neoplasms | 3 | 2006 | 1832 | 0.200 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 577 | 0.190 |
Why?
|
| Boronic Acids | 2 | 2016 | 965 | 0.190 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 76 | 0.190 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2019 | 735 | 0.190 |
Why?
|
| Semen | 1 | 2023 | 316 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2018 | 7730 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2012 | 625 | 0.190 |
Why?
|
| Molecular Typing | 1 | 2020 | 106 | 0.180 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1889 | 0.180 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2017 | 871 | 0.180 |
Why?
|
| Hydrazines | 1 | 2022 | 226 | 0.180 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 783 | 0.180 |
Why?
|
| Phosphorylation | 12 | 2019 | 8436 | 0.180 |
Why?
|
| Chromosome Mapping | 6 | 2021 | 4740 | 0.180 |
Why?
|
| Heptanes | 1 | 2019 | 8 | 0.180 |
Why?
|
| Disulfiram | 1 | 2020 | 57 | 0.180 |
Why?
|
| Lung Neoplasms | 15 | 2016 | 13104 | 0.180 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 144 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2023 | 9240 | 0.180 |
Why?
|
| Reproducibility of Results | 13 | 2021 | 19905 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2013 | 2916 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2018 | 2938 | 0.170 |
Why?
|
| Genes, BRCA1 | 2 | 2017 | 781 | 0.170 |
Why?
|
| Proteome | 1 | 2009 | 1798 | 0.170 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2012 | 1284 | 0.170 |
Why?
|
| Exons | 4 | 2012 | 2439 | 0.170 |
Why?
|
| Neoplasm, Residual | 2 | 2023 | 973 | 0.170 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 326 | 0.170 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2010 | 434 | 0.170 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2009 | 651 | 0.170 |
Why?
|
| RNA, Small Interfering | 9 | 2019 | 3505 | 0.170 |
Why?
|
| Genome | 4 | 2008 | 1807 | 0.160 |
Why?
|
| Piperazines | 5 | 2019 | 2488 | 0.160 |
Why?
|
| Receptors, Virus | 1 | 2022 | 649 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 4 | 2016 | 2007 | 0.160 |
Why?
|
| Phosphates | 1 | 2022 | 785 | 0.160 |
Why?
|
| Mice, Nude | 8 | 2019 | 3689 | 0.160 |
Why?
|
| Genetic Techniques | 3 | 2023 | 435 | 0.160 |
Why?
|
| Mutation, Missense | 5 | 2015 | 2566 | 0.160 |
Why?
|
| Cataloging | 1 | 2017 | 8 | 0.160 |
Why?
|
| Flow Cytometry | 12 | 2017 | 5974 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 162 | 0.160 |
Why?
|
| Melanocytes | 4 | 2012 | 515 | 0.160 |
Why?
|
| Female | 56 | 2024 | 380193 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2021 | 3554 | 0.160 |
Why?
|
| Purines | 2 | 2020 | 594 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2012 | 578 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2001 | 988 | 0.150 |
Why?
|
| HL-60 Cells | 5 | 2009 | 365 | 0.150 |
Why?
|
| Homeodomain Proteins | 6 | 2011 | 2418 | 0.150 |
Why?
|
| Ribosomes | 2 | 2013 | 500 | 0.150 |
Why?
|
| Homeostasis | 3 | 2022 | 3339 | 0.150 |
Why?
|
| Cytokines | 5 | 2018 | 7323 | 0.150 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 239 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 1369 | 0.150 |
Why?
|
| Molecular Sequence Data | 13 | 2012 | 18111 | 0.150 |
Why?
|
| Brain Stem Neoplasms | 1 | 2019 | 204 | 0.150 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 1788 | 0.150 |
Why?
|
| Disease Progression | 10 | 2015 | 13286 | 0.150 |
Why?
|
| Arenaviridae Infections | 1 | 2017 | 51 | 0.150 |
Why?
|
| Helix-Loop-Helix Motifs | 5 | 1997 | 96 | 0.150 |
Why?
|
| Cell Shape | 1 | 2018 | 375 | 0.150 |
Why?
|
| Protein Binding | 11 | 2023 | 9384 | 0.150 |
Why?
|
| Dipeptidases | 1 | 2016 | 38 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2017 | 2850 | 0.150 |
Why?
|
| Limonins | 2 | 2006 | 24 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2008 | 78 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 7 | 2017 | 5867 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2000 | 572 | 0.140 |
Why?
|
| Up-Regulation | 7 | 2018 | 4222 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2019 | 321 | 0.140 |
Why?
|
| Software | 7 | 2018 | 4441 | 0.140 |
Why?
|
| Receptors, Estrogen | 4 | 2018 | 2190 | 0.140 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 802 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2009 | 2987 | 0.140 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2016 | 88 | 0.140 |
Why?
|
| Blotting, Western | 8 | 2014 | 5181 | 0.140 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2007 | 105 | 0.140 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2016 | 27 | 0.140 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 18034 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 365 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2017 | 170 | 0.140 |
Why?
|
| Loss of Heterozygosity | 2 | 2016 | 684 | 0.140 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 4 | 2007 | 491 | 0.140 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 2133 | 0.140 |
Why?
|
| Neglected Diseases | 1 | 2016 | 64 | 0.140 |
Why?
|
| Pyrimidines | 6 | 2016 | 2943 | 0.140 |
Why?
|
| Caspase 1 | 1 | 2016 | 224 | 0.130 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cloning, Molecular | 3 | 1997 | 4320 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1996 | 146 | 0.130 |
Why?
|
| B-Lymphocytes | 2 | 2008 | 4666 | 0.130 |
Why?
|
| Oncogene Proteins | 3 | 2015 | 749 | 0.130 |
Why?
|
| Plasma Cells | 2 | 2016 | 591 | 0.130 |
Why?
|
| Anemia, Diamond-Blackfan | 2 | 2008 | 137 | 0.130 |
Why?
|
| Point Mutation | 5 | 2016 | 1624 | 0.130 |
Why?
|
| In Situ Hybridization | 5 | 2007 | 1950 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 12 | 2009 | 4751 | 0.130 |
Why?
|
| Microsatellite Instability | 1 | 2019 | 684 | 0.130 |
Why?
|
| Maltose-Binding Proteins | 1 | 2015 | 62 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2012 | 1085 | 0.130 |
Why?
|
| STAT Transcription Factors | 2 | 2014 | 182 | 0.130 |
Why?
|
| 14-3-3 Proteins | 1 | 2016 | 214 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2009 | 513 | 0.130 |
Why?
|
| Alleles | 4 | 2022 | 6933 | 0.130 |
Why?
|
| RNA-Binding Protein EWS | 3 | 2007 | 216 | 0.130 |
Why?
|
| Goals | 1 | 2021 | 707 | 0.130 |
Why?
|
| Myeloproliferative Disorders | 3 | 2014 | 606 | 0.130 |
Why?
|
| Gene Deletion | 9 | 2016 | 2751 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 3 | 2008 | 481 | 0.130 |
Why?
|
| Quantum Dots | 2 | 2007 | 172 | 0.130 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 131 | 0.130 |
Why?
|
| beta-Lactamases | 1 | 2017 | 306 | 0.130 |
Why?
|
| Male | 58 | 2023 | 350115 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2012 | 11525 | 0.130 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2012 | 75 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2020 | 553 | 0.130 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 279 | 0.130 |
Why?
|
| Janus Kinases | 2 | 2014 | 244 | 0.130 |
Why?
|
| Multigene Family | 6 | 2018 | 1102 | 0.120 |
Why?
|
| Chromosome Deletion | 5 | 2011 | 1401 | 0.120 |
Why?
|
| Sirolimus | 4 | 2006 | 1565 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 2 | 2013 | 96 | 0.120 |
Why?
|
| Mediastinal Neoplasms | 3 | 2015 | 423 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3084 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1222 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2010 | 1115 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4208 | 0.120 |
Why?
|
| Dipeptides | 1 | 2016 | 409 | 0.120 |
Why?
|
| Nuclear Proteins | 7 | 2022 | 5856 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 2018 | 517 | 0.120 |
Why?
|
| Mice, Inbred NOD | 6 | 2021 | 1879 | 0.120 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2014 | 98 | 0.120 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.120 |
Why?
|
| Serine Proteases | 1 | 2014 | 52 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2016 | 2110 | 0.120 |
Why?
|
| Acute Disease | 6 | 2015 | 7147 | 0.120 |
Why?
|
| International Cooperation | 1 | 2021 | 1420 | 0.120 |
Why?
|
| Cyclin D1 | 4 | 2018 | 463 | 0.120 |
Why?
|
| Systems Biology | 1 | 2017 | 469 | 0.120 |
Why?
|
| Models, Biological | 7 | 2018 | 9584 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
| Histones | 5 | 2019 | 2598 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2013 | 20 | 0.120 |
Why?
|
| Cell Cycle | 4 | 2012 | 2967 | 0.120 |
Why?
|
| Models, Molecular | 6 | 2020 | 5451 | 0.120 |
Why?
|
| Amino Acid Sequence | 6 | 2011 | 13814 | 0.120 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 9735 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2016 | 880 | 0.110 |
Why?
|
| Drug Synergism | 4 | 2018 | 1794 | 0.110 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2007 | 286 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 180 | 0.110 |
Why?
|
| Primary Myelofibrosis | 2 | 2006 | 215 | 0.110 |
Why?
|
| Lovastatin | 1 | 2013 | 120 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 489 | 0.110 |
Why?
|
| Ribonuclease III | 3 | 2010 | 275 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2017 | 826 | 0.110 |
Why?
|
| Cell Division | 9 | 2007 | 4569 | 0.110 |
Why?
|
| Predictive Value of Tests | 10 | 2015 | 15078 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5077 | 0.110 |
Why?
|
| Mediator Complex | 2 | 2012 | 109 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2016 | 2504 | 0.110 |
Why?
|
| Glutamates | 1 | 2014 | 398 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 535 | 0.110 |
Why?
|
| Janus Kinase 2 | 3 | 2014 | 528 | 0.110 |
Why?
|
| Genes, Essential | 3 | 2019 | 183 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2012 | 53 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2012 | 647 | 0.110 |
Why?
|
| NF-kappa B | 4 | 2013 | 2499 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 196 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 1917 | 0.110 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 1151 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2017 | 914 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2004 | 4162 | 0.110 |
Why?
|
| Epithelial Cells | 9 | 2019 | 3690 | 0.110 |
Why?
|
| Proline | 1 | 2014 | 458 | 0.110 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 20 | 0.110 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2012 | 57 | 0.110 |
Why?
|
| Gene Library | 4 | 2018 | 1074 | 0.100 |
Why?
|
| Molecular Structure | 3 | 2022 | 1899 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2006 | 294 | 0.100 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 915 | 0.100 |
Why?
|
| Genes, p53 | 2 | 2012 | 755 | 0.100 |
Why?
|
| Transfection | 9 | 2012 | 5895 | 0.100 |
Why?
|
| Enzyme Activation | 7 | 2019 | 3702 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 1213 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2441 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2018 | 10252 | 0.100 |
Why?
|
| K562 Cells | 3 | 2008 | 635 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2012 | 286 | 0.100 |
Why?
|
| Dioxolanes | 1 | 2011 | 25 | 0.100 |
Why?
|
| Paraffin Embedding | 2 | 2012 | 299 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2014 | 436 | 0.100 |
Why?
|
| Tissue Fixation | 2 | 2012 | 241 | 0.100 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2008 | 30 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2021 | 3309 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 990 | 0.100 |
Why?
|
| DNA Primers | 4 | 2006 | 2891 | 0.100 |
Why?
|
| Spliceosomes | 1 | 2011 | 110 | 0.100 |
Why?
|
| Nitriles | 2 | 2014 | 955 | 0.100 |
Why?
|
| Gene Silencing | 3 | 2017 | 1539 | 0.100 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 128 | 0.100 |
Why?
|
| DNA Repair | 2 | 2011 | 2046 | 0.100 |
Why?
|
| False Positive Reactions | 2 | 2013 | 980 | 0.100 |
Why?
|
| Herpesvirus 4, Human | 2 | 2007 | 1041 | 0.100 |
Why?
|
| Base Sequence | 9 | 2020 | 12797 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2008 | 67 | 0.100 |
Why?
|
| YY1 Transcription Factor | 1 | 2011 | 60 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2021 | 8319 | 0.090 |
Why?
|
| Response Elements | 2 | 2010 | 312 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 994 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2016 | 1915 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2011 | 1142 | 0.090 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.090 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2010 | 36 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
| Genetic Engineering | 1 | 2016 | 951 | 0.090 |
Why?
|
| Ribonucleases | 1 | 2011 | 287 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2011 | 163 | 0.090 |
Why?
|
| Dexamethasone | 3 | 2006 | 1951 | 0.090 |
Why?
|
| Estrogens | 2 | 2008 | 1566 | 0.090 |
Why?
|
| Genes, Reporter | 4 | 2008 | 1547 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 122 | 0.090 |
Why?
|
| Pyridines | 2 | 2020 | 2825 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2017 | 2716 | 0.090 |
Why?
|
| Protein Array Analysis | 2 | 2019 | 411 | 0.090 |
Why?
|
| Erythroid Precursor Cells | 2 | 2008 | 218 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 8949 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1837 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2009 | 459 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 21833 | 0.090 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 246 | 0.090 |
Why?
|
| Polycythemia Vera | 2 | 2005 | 164 | 0.090 |
Why?
|
| Antimalarials | 1 | 2016 | 905 | 0.090 |
Why?
|
| Macrophages | 5 | 2017 | 5660 | 0.090 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 806 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 937 | 0.090 |
Why?
|
| Hodgkin Disease | 2 | 2010 | 1415 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 2736 | 0.090 |
Why?
|
| Ectoderm | 1 | 2009 | 137 | 0.090 |
Why?
|
| Research Report | 1 | 2012 | 355 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2012 | 1692 | 0.080 |
Why?
|
| Histone Deacetylases | 3 | 2019 | 728 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 261 | 0.080 |
Why?
|
| Indoles | 3 | 2012 | 1839 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 881 | 0.080 |
Why?
|
| Normal Distribution | 1 | 2009 | 280 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2009 | 106 | 0.080 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2015 | 895 | 0.080 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 129 | 0.080 |
Why?
|
| Antigens, CD34 | 2 | 2008 | 659 | 0.080 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2008 | 47 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2014 | 1189 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2917 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 727 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 652 | 0.080 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 53 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2010 | 229 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2213 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1341 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 2005 | 71 | 0.080 |
Why?
|
| Cell Cycle Proteins | 5 | 2015 | 3464 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 502 | 0.080 |
Why?
|
| Hepatocytes | 2 | 2014 | 1211 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
| Phenotype | 7 | 2016 | 16367 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2008 | 415 | 0.080 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2008 | 62 | 0.080 |
Why?
|
| Mammals | 2 | 2022 | 1143 | 0.080 |
Why?
|
| GATA4 Transcription Factor | 1 | 2009 | 131 | 0.080 |
Why?
|
| Germinal Center | 1 | 2011 | 377 | 0.080 |
Why?
|
| Methylation | 1 | 2011 | 1106 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2017 | 894 | 0.080 |
Why?
|
| Retinoids | 1 | 2008 | 101 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 2540 | 0.080 |
Why?
|
| Immunoblotting | 5 | 2017 | 1683 | 0.080 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 130 | 0.080 |
Why?
|
| Histone Code | 2 | 2019 | 163 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2023 | 4446 | 0.080 |
Why?
|
| Microspheres | 2 | 2009 | 777 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2008 | 122 | 0.080 |
Why?
|
| Androgens | 2 | 2006 | 1281 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 249 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 3130 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 375 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1641 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 2 | 2013 | 594 | 0.070 |
Why?
|
| Internet | 2 | 2017 | 3056 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2008 | 175 | 0.070 |
Why?
|
| Genotype | 5 | 2016 | 12952 | 0.070 |
Why?
|
| Fluorometry | 1 | 2007 | 106 | 0.070 |
Why?
|
| E2F Transcription Factors | 3 | 2017 | 277 | 0.070 |
Why?
|
| Molecular Probes | 1 | 2009 | 316 | 0.070 |
Why?
|
| Metribolone | 1 | 2006 | 13 | 0.070 |
Why?
|
| Consensus Sequence | 1 | 2007 | 378 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2015 | 4010 | 0.070 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2006 | 37 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 3 | 2023 | 2727 | 0.070 |
Why?
|
| Phenothiazines | 1 | 2006 | 63 | 0.070 |
Why?
|
| Granulocytes | 3 | 2006 | 548 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2012 | 1355 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 245 | 0.070 |
Why?
|
| CpG Islands | 1 | 2011 | 1170 | 0.070 |
Why?
|
| RNA Precursors | 1 | 2008 | 209 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2216 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2024 | 6386 | 0.070 |
Why?
|
| Algorithms | 11 | 2018 | 13882 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2018 | 3444 | 0.070 |
Why?
|
| Databases, Genetic | 4 | 2017 | 1783 | 0.070 |
Why?
|
| Retroviridae | 3 | 2006 | 914 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 1636 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2020 | 671 | 0.070 |
Why?
|
| Malaria | 1 | 2016 | 1239 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2417 | 0.070 |
Why?
|
| Triterpenes | 1 | 2006 | 80 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5263 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2009 | 3130 | 0.070 |
Why?
|
| Erythropoietin | 2 | 2008 | 726 | 0.070 |
Why?
|
| Staurosporine | 2 | 2007 | 251 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2076 | 0.070 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2006 | 48 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2015 | 2575 | 0.070 |
Why?
|
| Endoderm | 1 | 2007 | 154 | 0.070 |
Why?
|
| Thrombopoietin | 1 | 2008 | 225 | 0.070 |
Why?
|
| Benzoquinones | 1 | 2006 | 201 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 373 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2008 | 551 | 0.070 |
Why?
|
| Protein Kinases | 4 | 2009 | 1640 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2009 | 620 | 0.070 |
Why?
|
| Molecular Weight | 2 | 2007 | 2255 | 0.070 |
Why?
|
| Chromatin | 5 | 2019 | 2933 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2012 | 1940 | 0.070 |
Why?
|
| Treatment Outcome | 11 | 2018 | 63107 | 0.070 |
Why?
|
| Blotting, Northern | 4 | 2002 | 1581 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2009 | 721 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2006 | 1375 | 0.060 |
Why?
|
| Prostate | 4 | 2011 | 1775 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 12262 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2007 | 207 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 2513 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2014 | 5223 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 689 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1127 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2256 | 0.060 |
Why?
|
| Proteins | 6 | 2009 | 6100 | 0.060 |
Why?
|
| Viral Matrix Proteins | 1 | 2005 | 186 | 0.060 |
Why?
|
| Child | 14 | 2022 | 77709 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 10943 | 0.060 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 320 | 0.060 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 113 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2024 | 14723 | 0.060 |
Why?
|
| Karyotyping | 3 | 1997 | 1243 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 570 | 0.060 |
Why?
|
| Cyclin A | 1 | 2004 | 60 | 0.060 |
Why?
|
| Middle Aged | 19 | 2020 | 213390 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 1059 | 0.060 |
Why?
|
| Classification | 1 | 2004 | 129 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 105 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2014 | 1660 | 0.060 |
Why?
|
| Cisplatin | 1 | 2010 | 1662 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 706 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2015 | 2649 | 0.060 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2002 | 166 | 0.060 |
Why?
|
| Adult | 20 | 2023 | 214052 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 103 | 0.060 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2003 | 76 | 0.060 |
Why?
|
| Genes, ras | 3 | 2012 | 690 | 0.060 |
Why?
|
| Ligands | 3 | 2018 | 3282 | 0.060 |
Why?
|
| Cell Nucleus | 5 | 2008 | 2969 | 0.060 |
Why?
|
| Nasopharynx | 1 | 2005 | 379 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 634 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 286 | 0.060 |
Why?
|
| Time Factors | 7 | 2021 | 40075 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2015 | 4034 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 1656 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2000 | 3144 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 675 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 1585 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 3 | 2011 | 356 | 0.050 |
Why?
|
| Interferons | 2 | 2023 | 706 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2008 | 1352 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2020 | 5101 | 0.050 |
Why?
|
| Thalidomide | 1 | 2008 | 890 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2000 | 1364 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 692 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 2012 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2014 | 203 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2002 | 255 | 0.050 |
Why?
|
| Tetracyclines | 1 | 2002 | 60 | 0.050 |
Why?
|
| DNA Methylation | 4 | 2019 | 4285 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1997 | 2839 | 0.050 |
Why?
|
| Dimerization | 2 | 2010 | 895 | 0.050 |
Why?
|
| Starvation | 1 | 2002 | 134 | 0.050 |
Why?
|
| Disease | 1 | 2007 | 680 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 602 | 0.050 |
Why?
|
| Aged | 16 | 2020 | 163288 | 0.050 |
Why?
|
| Lymphoma | 1 | 2011 | 1877 | 0.050 |
Why?
|
| Chromosome Breakpoints | 2 | 2012 | 98 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2015 | 3773 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2010 | 4026 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2009 | 1379 | 0.050 |
Why?
|
| Thiazoles | 1 | 2008 | 1483 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2307 | 0.050 |
Why?
|
| Syndrome | 1 | 2008 | 3252 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1793 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2021 | 329 | 0.050 |
Why?
|
| RNA Splicing | 2 | 2019 | 908 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2011 | 1880 | 0.050 |
Why?
|
| Diploidy | 1 | 2021 | 138 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4424 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 333 | 0.050 |
Why?
|
| GAP-43 Protein | 1 | 2000 | 152 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1596 | 0.050 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2002 | 236 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2014 | 250 | 0.050 |
Why?
|
| Genes, Lethal | 1 | 2021 | 242 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2012 | 6773 | 0.050 |
Why?
|
| Iron | 1 | 2008 | 1774 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 1997 | 803 | 0.050 |
Why?
|
| Fixatives | 2 | 2012 | 94 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2011 | 2119 | 0.050 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 127 | 0.050 |
Why?
|
| Sample Size | 2 | 2014 | 845 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 707 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1903 | 0.040 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 437 | 0.040 |
Why?
|
| Glucocorticoids | 2 | 2006 | 2108 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1524 | 0.040 |
Why?
|
| raf Kinases | 2 | 2011 | 122 | 0.040 |
Why?
|
| Vincristine | 1 | 2002 | 1039 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2021 | 235 | 0.040 |
Why?
|
| Carcinoma | 1 | 2011 | 2375 | 0.040 |
Why?
|
| Sequence Deletion | 4 | 2011 | 1525 | 0.040 |
Why?
|
| Oligonucleotide Probes | 3 | 2007 | 427 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1295 | 0.040 |
Why?
|
| DNA Damage | 3 | 2016 | 2432 | 0.040 |
Why?
|
| Carrier Proteins | 4 | 2011 | 5023 | 0.040 |
Why?
|
| Child, Preschool | 9 | 2015 | 41005 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6621 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 3 | 2013 | 3616 | 0.040 |
Why?
|
| Tretinoin | 1 | 2002 | 517 | 0.040 |
Why?
|
| Transcription Factors, TFII | 1 | 1998 | 60 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2005 | 670 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2000 | 250 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 1678 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 293 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2018 | 1958 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3255 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39052 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 2008 | 2050 | 0.040 |
Why?
|
| Pons | 1 | 2019 | 245 | 0.040 |
Why?
|
| Immunohistochemistry | 6 | 2015 | 11366 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 1828 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2019 | 40559 | 0.040 |
Why?
|
| Formaldehyde | 2 | 2012 | 353 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2018 | 96 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 3 | 2005 | 252 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 370 | 0.040 |
Why?
|
| Sarcoma | 1 | 2009 | 1897 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 1988 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cervix Uteri | 3 | 1991 | 590 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2020 | 289 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2005 | 2926 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 378 | 0.040 |
Why?
|
| Genome, Fungal | 1 | 1998 | 204 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 200 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 15520 | 0.040 |
Why?
|
| Yolk Sac | 1 | 1997 | 75 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 399 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 1999 | 743 | 0.040 |
Why?
|
| Survival Rate | 5 | 2020 | 12788 | 0.040 |
Why?
|
| Oocytes | 1 | 2002 | 1188 | 0.040 |
Why?
|
| Infant | 7 | 2015 | 35134 | 0.040 |
Why?
|
| Genes, Viral | 2 | 2005 | 718 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2018 | 245 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 234 | 0.040 |
Why?
|
| Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2018 | 185 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1199 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2022 | 861 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 547 | 0.040 |
Why?
|
| Genes, abl | 1 | 1997 | 72 | 0.040 |
Why?
|
| Oxygen | 1 | 2008 | 4189 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 2017 | 90 | 0.040 |
Why?
|
| Prednisone | 1 | 2002 | 1574 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 134 | 0.040 |
Why?
|
| Leukemia, B-Cell | 1 | 1997 | 86 | 0.040 |
Why?
|
| Interleukin-3 | 3 | 2005 | 444 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 393 | 0.040 |
Why?
|
| Metabolome | 1 | 2023 | 895 | 0.040 |
Why?
|
| Life Tables | 1 | 1996 | 370 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2018 | 367 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1158 | 0.040 |
Why?
|
| Papillomaviridae | 3 | 2011 | 1119 | 0.040 |
Why?
|
| Thionucleosides | 1 | 2016 | 13 | 0.040 |
Why?
|
| Hematopoietic System | 1 | 1996 | 109 | 0.040 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 57776 | 0.040 |
Why?
|
| Deoxyadenosines | 1 | 2016 | 27 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 168 | 0.040 |
Why?
|
| Cells | 1 | 2017 | 168 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3848 | 0.030 |
Why?
|
| Pharmacogenetics | 2 | 2012 | 674 | 0.030 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3646 | 0.030 |
Why?
|
| Amino Acids | 1 | 2002 | 1737 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2016 | 58 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1998 | 502 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 323 | 0.030 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 1995 | 17 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2001 | 794 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2242 | 0.030 |
Why?
|
| U937 Cells | 2 | 2009 | 268 | 0.030 |
Why?
|
| Autopsy | 1 | 2019 | 1020 | 0.030 |
Why?
|
| Protein Folding | 1 | 2019 | 840 | 0.030 |
Why?
|
| Pyridones | 1 | 2020 | 711 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 890 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 599 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2002 | 1701 | 0.030 |
Why?
|
| Apoproteins | 1 | 2015 | 44 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2219 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2020 | 1012 | 0.030 |
Why?
|
| Serine | 1 | 2019 | 826 | 0.030 |
Why?
|
| Homozygote | 2 | 2014 | 1787 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2014 | 1892 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 2014 | 17 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2016 | 562 | 0.030 |
Why?
|
| Testosterone | 1 | 2006 | 2419 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2002 | 2234 | 0.030 |
Why?
|
| Mutant Proteins | 2 | 2007 | 500 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 381 | 0.030 |
Why?
|
| Adipocytes | 1 | 2002 | 1185 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1997 | 327 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2000 | 1185 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 539 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2006 | 3424 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2001 | 2971 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12244 | 0.030 |
Why?
|
| Mucin-1 | 1 | 2019 | 543 | 0.030 |
Why?
|
| Kinetics | 1 | 2022 | 6476 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 1998 | 550 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 38 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 594 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2007 | 2789 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2014 | 64 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 976 | 0.030 |
Why?
|
| National Health Programs | 1 | 2017 | 445 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 525 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2007 | 442 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 780 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 618 | 0.030 |
Why?
|
| Receptor, trkB | 1 | 2014 | 125 | 0.030 |
Why?
|
| Luciferases | 2 | 2007 | 733 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3207 | 0.030 |
Why?
|
| Biopsy | 3 | 2015 | 6755 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2014 | 21748 | 0.030 |
Why?
|
| Receptor, trkA | 1 | 2014 | 164 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 940 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 188 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| Glucose | 2 | 2003 | 4398 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2015 | 383 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 542 | 0.030 |
Why?
|
| Calreticulin | 1 | 2014 | 98 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 109 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 1586 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 808 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2015 | 698 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 453 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 5984 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 1809 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 4153 | 0.030 |
Why?
|
| Myeloid Cells | 2 | 2009 | 810 | 0.030 |
Why?
|
| Benzofurans | 1 | 2013 | 140 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 45 | 0.030 |
Why?
|
| Bile Ducts | 1 | 2014 | 284 | 0.030 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 6896 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2121 | 0.030 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2012 | 18 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 130 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1099 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2383 | 0.030 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14561 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 851 | 0.030 |
Why?
|
| Genes, p16 | 1 | 2012 | 157 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1276 | 0.030 |
Why?
|
| Probability | 2 | 2007 | 2506 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2017 | 824 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2002 | 3864 | 0.030 |
Why?
|
| SOS1 Protein | 1 | 2011 | 41 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 53290 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1998 | 3587 | 0.030 |
Why?
|
| Comet Assay | 1 | 2011 | 71 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 677 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 2010 | 5692 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 627 | 0.020 |
Why?
|
| Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 2012 | 220 | 0.020 |
Why?
|
| Adolescent | 8 | 2015 | 85779 | 0.020 |
Why?
|
| Coumarins | 1 | 2011 | 119 | 0.020 |
Why?
|
| Neuroglia | 1 | 2016 | 928 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 4925 | 0.020 |
Why?
|
| Telomere-Binding Proteins | 1 | 2011 | 116 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 317 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 548 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1584 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 413 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 351 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6366 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2010 | 34 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3749 | 0.020 |
Why?
|
| Immune Evasion | 1 | 2014 | 360 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 74 | 0.020 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 199 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 644 | 0.020 |
Why?
|
| Neurofibromin 1 | 1 | 2011 | 196 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2012 | 576 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 689 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2003 | 12961 | 0.020 |
Why?
|
| Tyrosine | 2 | 2009 | 1462 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 1997 | 1351 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 209 | 0.020 |
Why?
|
| Mitosis | 2 | 2005 | 1208 | 0.020 |
Why?
|
| Rats | 4 | 2014 | 24252 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 457 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3873 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 841 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 1377 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 137 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 390 | 0.020 |
Why?
|
| Drug Design | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Interleukins | 1 | 2014 | 791 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1988 | 0.020 |
Why?
|
| United States | 4 | 2020 | 69872 | 0.020 |
Why?
|
| Indole Alkaloids | 1 | 2009 | 24 | 0.020 |
Why?
|
| Immunophilins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3771 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2385 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 851 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 408 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 705 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 294 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 215 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2804 | 0.020 |
Why?
|
| Gene Fusion | 1 | 2012 | 371 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 428 | 0.020 |
Why?
|
| Penetrance | 1 | 2011 | 381 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 671 | 0.020 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2008 | 32 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 1887 | 0.020 |
Why?
|
| Core Binding Factors | 1 | 2008 | 31 | 0.020 |
Why?
|
| Financing, Government | 1 | 2012 | 468 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 25628 | 0.020 |
Why?
|
| Fluorescence | 1 | 2011 | 751 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 496 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1267 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 209 | 0.020 |
Why?
|
| Epithelium | 3 | 2006 | 1679 | 0.020 |
Why?
|
| Africa | 1 | 2010 | 672 | 0.020 |
Why?
|
| Spleen | 2 | 2006 | 2362 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2148 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1264 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 705 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2008 | 246 | 0.020 |
Why?
|
| Oxazines | 1 | 2009 | 298 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 2751 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1736 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1995 | 1381 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 139 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1157 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 169 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2618 | 0.020 |
Why?
|
| Carcinogenicity Tests | 1 | 2007 | 41 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 111 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 537 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 406 | 0.020 |
Why?
|
| Carbazoles | 1 | 2009 | 226 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1431 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 296 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1088 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 287 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 9857 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1060 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2010 | 977 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 11031 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2009 | 569 | 0.020 |
Why?
|
| Protein Stability | 1 | 2008 | 556 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
| Cyclin D | 1 | 2006 | 72 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 1169 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 2012 | 636 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 322 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2006 | 39 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 321 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2703 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3480 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2006 | 29 | 0.020 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2006 | 34 | 0.020 |
Why?
|
| Viscera | 1 | 2007 | 139 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1549 | 0.020 |
Why?
|
| Morpholines | 1 | 2009 | 571 | 0.020 |
Why?
|
| Binding Sites | 2 | 2008 | 6111 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2638 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2006 | 81 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 98 | 0.020 |
Why?
|
| Blastocyst | 1 | 2009 | 424 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1084 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 675 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.020 |
Why?
|
| Diphenylamine | 1 | 2005 | 50 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2725 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1707 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 3177 | 0.020 |
Why?
|
| Keratinocytes | 1 | 1990 | 799 | 0.020 |
Why?
|
| Stem Cells | 3 | 2005 | 3567 | 0.020 |
Why?
|
| Calcium | 2 | 2017 | 5755 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1613 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2007 | 2716 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2009 | 542 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 186 | 0.020 |
Why?
|
| Microdissection | 1 | 2006 | 152 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 108 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 838 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2542 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 8038 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 262 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 7914 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 452 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2004 | 21 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
| Sweden | 1 | 2008 | 1341 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2004 | 39 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 473 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2006 | 293 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 1996 | 323 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2001 | 1880 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2004 | 11 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2005 | 151 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 479 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2005 | 219 | 0.020 |
Why?
|
| Artifacts | 1 | 2013 | 1904 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1247 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 191 | 0.020 |
Why?
|
| Phenols | 1 | 2008 | 497 | 0.020 |
Why?
|
| G1 Phase | 1 | 2005 | 415 | 0.020 |
Why?
|
| Obesity | 1 | 2006 | 12746 | 0.010 |
Why?
|
| Cholesterol | 1 | 2013 | 2919 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2008 | 1655 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7182 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2003 | 50 | 0.010 |
Why?
|
| Insulin | 3 | 2003 | 6582 | 0.010 |
Why?
|
| Mesoderm | 1 | 2007 | 686 | 0.010 |
Why?
|
| Flavonoids | 1 | 2006 | 443 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7184 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 898 | 0.010 |
Why?
|
| S Phase | 1 | 2004 | 423 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 1157 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2003 | 104 | 0.010 |
Why?
|
| Animals, Congenic | 1 | 2002 | 27 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 767 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 644 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 103 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 2924 | 0.010 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1677 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2002 | 223 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 1073 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 817 | 0.010 |
Why?
|
| RNA | 2 | 2003 | 2749 | 0.010 |
Why?
|
| Osteopetrosis | 1 | 2002 | 43 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2007 | 1035 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1865 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5096 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77460 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 192 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 320 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 795 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 434 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2002 | 347 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 205 | 0.010 |
Why?
|
| Neurons | 2 | 2017 | 9340 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 895 | 0.010 |
Why?
|
| Microtubules | 1 | 2008 | 1089 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2897 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 238 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.010 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2002 | 83 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2002 | 250 | 0.010 |
Why?
|
| Metalloproteins | 1 | 2002 | 100 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 142 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 141 | 0.010 |
Why?
|
| Lasers | 1 | 2006 | 952 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1202 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2634 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 389 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1991 | 2020 | 0.010 |
Why?
|
| Enzymes | 1 | 2002 | 266 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2002 | 270 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 2494 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2088 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 402 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2007 | 570 | 0.010 |
Why?
|
| Estradiol | 1 | 2008 | 2020 | 0.010 |
Why?
|
| Thymosin | 1 | 2000 | 47 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2001 | 286 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 595 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3528 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 440 | 0.010 |
Why?
|
| Smoking | 2 | 2011 | 8987 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 627 | 0.010 |
Why?
|
| Bradykinin | 1 | 2000 | 214 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 331 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1629 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 3912 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2006 | 1005 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1009 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 730 | 0.010 |
Why?
|
| Placebos | 1 | 2004 | 1676 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2002 | 525 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 1587 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2000 | 547 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2038 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 11726 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 420 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2000 | 291 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 241 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1161 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 1998 | 52 | 0.010 |
Why?
|
| Genes, cdc | 1 | 1998 | 116 | 0.010 |
Why?
|
| Immunity | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 9955 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2804 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1998 | 151 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2002 | 729 | 0.010 |
Why?
|
| Neurites | 1 | 2000 | 388 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 2475 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 2765 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1227 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Health Surveys | 1 | 2008 | 4036 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 2000 | 397 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 1972 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2006 | 880 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2274 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 1998 | 234 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2887 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 1998 | 198 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1663 | 0.010 |
Why?
|
| Chimera | 1 | 1998 | 485 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2006 | 1890 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1996 | 179 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1998 | 455 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2003 | 1173 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1996 | 103 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 1998 | 335 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2000 | 466 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 726 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 438 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2002 | 1166 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1751 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 335 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9688 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3486 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1783 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1225 | 0.010 |
Why?
|
| Nerve Regeneration | 1 | 2000 | 788 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1998 | 912 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 560 | 0.010 |
Why?
|
| Zebrafish | 1 | 2005 | 2996 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56429 | 0.010 |
Why?
|
| Placenta | 1 | 2002 | 1699 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2865 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1995 | 514 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1862 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 878 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2002 | 3280 | 0.010 |
Why?
|
| Physicians | 1 | 2008 | 4567 | 0.010 |
Why?
|
| Desmosomes | 1 | 1989 | 73 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 1340 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2003 | 6194 | 0.010 |
Why?
|
| Neutrophils | 1 | 2001 | 3721 | 0.010 |
Why?
|
| Hippocampus | 1 | 2000 | 3675 | 0.000 |
Why?
|
| Keratins | 1 | 1989 | 515 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1989 | 410 | 0.000 |
Why?
|
| Culture Media | 1 | 1989 | 909 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3617 | 0.000 |
Why?
|
| Recurrence | 1 | 1998 | 8340 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1990 | 1101 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 2646 | 0.000 |
Why?
|
| Heart Failure | 1 | 2009 | 10895 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1989 | 2505 | 0.000 |
Why?
|
| Plasmids | 1 | 1990 | 2308 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10183 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5445 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1536 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 2227 | 0.000 |
Why?
|
| Endoplasmic Reticulum | 1 | 1989 | 1146 | 0.000 |
Why?
|
| Pregnancy | 2 | 1998 | 29144 | 0.000 |
Why?
|
| Fetus | 1 | 1990 | 1880 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 20952 | 0.000 |
Why?
|
| Skin | 1 | 1990 | 4372 | 0.000 |
Why?
|
| Risk Factors | 1 | 2002 | 72296 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 9274 | 0.000 |
Why?
|